CSL Behring L.L.C.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1201 N Kinzie Ave, Bradley, Illinois (IL) 60915, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 1410248 · DUNS 058268293
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIBlood and Blood Products2023-03-02
- VAIBlood and Blood Products2021-09-24
- VAIVaccines and Allergenic Products2021-09-24
- VAIBlood and Blood Products2019-05-23
- VAIVaccines and Allergenic Products2019-05-23
- VAIBlood and Blood Products2018-10-18
- VAIBlood and Blood Products2017-07-19
- VAIVaccines and Allergenic Products2017-07-19
- VAIBlood and Blood Products2015-07-17
- VAIVaccines and Allergenic Products2015-07-17
- VAIDrug Quality Assurance2014-07-28
- NAIDrug Quality Assurance2013-05-30
- NAIBlood and Blood Products2012-09-10
- NAIDrug Quality Assurance2012-09-10
- VAIBlood and Blood Products2011-02-03
- VAIDrug Quality Assurance2009-06-05
- VAIBlood and Blood Products2009-03-26
Drugs this plant is listed as making
1 distinct drugs across 39 products name this site in their FDA label.
- etranacogene dezaparvovecCSL Behring
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.